facebook
twitter
rss
account
search
search
 

FDA rejects Byetta data

Nov. 6, 2008 at 12:04 AM   |   Comments

WASHINGTON, Nov. 6 (UPI) -- The U.S. Food and Drug Administration has rejected research data for a long-acting version of the diabetes drug Byetta.

The FDA rejected Eli Lilly's studies comparing small-scale batches of Byetta LAR made by partner Alkermes to large-scale batches made at an Amylin Pharmaceuticals manufacturing plant, Amylin said. Conducting a new study could delay the company's plans to seek approval next year, the Indianapolis Star reported.

The version of Byetta currently on the market is a twice-a-day injectable drug to help diabetics control their blood sugar, the newspaper said.

© 2008 United Press International, Inc. All Rights Reserved. Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.
Recommended UPI Stories
Most Popular
1
Newfoundland fossil is earliest evidence of muscled animals
2
Tech industry All Stars developing 'Star Trek'-style communication badges
3
Study: gamblers' brains not unlike those of pigeons
4
Latvia boasts world's first net for migrating bats
5
Neanderthals and humans interacted for thousands of years
Trending News
Video
x
Feedback